{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:27:43Z","timestamp":1777386463206,"version":"3.51.4"},"reference-count":15,"publisher":"SLACK, Inc.","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Refract Surg"],"published-print":{"date-parts":[[2008,5]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>To compare the recovery of uncorrected visual acuity (UCVA) following LASIK in patients treated with topical cyclosporine A 0.05% and patients treated with a standard postoperative regimen.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this single-center, open-label, retrospective study, a standard refractive workup was performed in 45 patients (85 eyes) who underwent LASIK and did not have preexisting dry eye. In 36 eyes, a standard postoperative eye drop regimen was followed, and in 49 eyes, cyclosporine A 0.05% was added to the standard regimen for 12 weeks. Uncorrected visual acuity was measured 1 week and 1 and 3 months postoperatively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>One week postoperatively, 22 (44.9%) eyes in the cyclosporine A group and 8 (22.2%) eyes in the standard treatment group had UCVA of 20\/15. Cumulatively, 36 (73.5%) eyes in the cyclosporine A group and 24 (66.7%) eyes in the standard treatment group had UCVA of 20\/20 or better. One month postoperatively, 37 (75.5%) in the cyclosporine A group and 23 (63.9%) eyes in the standard treatment group had UCVA of 20\/20 or better. Three months postoperatively, 40 (81.6%) eyes in the cyclosporine A group and 25 (69.4%) eyes in the standard treatment group had UCVA of 20\/20 or better. Mean UCVA in the cyclosporine A group showed statistically significant improvements compared with the standard treatment group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>\n              Cyclosporine A 0.05%, in the form of Restasis, may be an effective treatment for reducing the time needed for visual recovery after LASIK. Use of cyclosporine A was associated with overall better and faster recovery of UCVA. [\n              <jats:italic>J Refract Surg<\/jats:italic>\n              . 2008;24:473\u2013476.]\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.3928\/1081597x-20080501-04","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T18:47:00Z","timestamp":1549910820000},"page":"473-476","source":"Crossref","is-referenced-by-count":31,"title":["The Effect of Cyclosporine A (Restasis) on Recovery of Visual Acuity Following LASIK"],"prefix":"10.3928","volume":"24","author":[{"given":"Roxana","family":"Ursea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy L.","family":"Purcell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan U.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniruddha","family":"Nalgirkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario E.","family":"Lovaton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Ehrenhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Schanzlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200101000-00005"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081-597X-20031101-05"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081-597X-20040101-11"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000080937"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)00176-1"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2005.10.034"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2005.02.041"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.04.034"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2003.10.024"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(02)02228-7"},{"key":"e_1_3_1_12_2","first-page":"8","article-title":"Dealing with dry eye","volume":"39","author":"Meadows M","year":"2005","unstructured":"Meadows M. Dealing with dry eye. FDA Consum. 2005;39:8\u20139.","journal-title":"FDA Consum"},{"key":"e_1_3_1_13_2","first-page":"153","article-title":"New perspectives in ocular surface disorders. An integrated approach for diagnosis and management","volume":"49","author":"Sangwan VS","year":"2001","unstructured":"Sangwan VS, Tseng SC. New perspectives in ocular surface disorders. An integrated approach for diagnosis and management. Indian J Ophthalmol. 2001;49:153\u2013168.","journal-title":"Indian J Ophthalmol"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00347-004-1153-7"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2003.09.003"},{"key":"e_1_3_1_16_2","volume-title":"Presented at: American Geriatric Society Annual Scientific Meeting","author":"Herrygers L","unstructured":"Herrygers L, Noecker R. Efficacy of cyclosporine A (Restasis) for the treatment of dry eye symptoms in the first 30 days. Presented at: American Geriatric Society Annual Scientific Meeting; May 11\u201315, 2005; Orlando, Fla."}],"container-title":["Journal of Refractive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.healio.com\/ophthalmology\/refractive-surgery\/journals\/jrs\/2008-5-24-5\/%7B7b77179b-e797-40ea-bea5-a0af262ec244%7D\/the-effect-of-cyclosporine-a-restasis-on-recovery-of-visual-acuity-following-lasik","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:38:45Z","timestamp":1728923925000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/1081597X-20080501-04"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["10.3928\/1081597X-20080501-04"],"URL":"https:\/\/doi.org\/10.3928\/1081597x-20080501-04","relation":{},"ISSN":["1081-597X"],"issn-type":[{"value":"1081-597X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}